Antimicrobial Stewardship & Healthcare Epidemiology (Jan 2024)

The epidemiology of Stenotrophomonas maltophilia and Achromobacter xylosoxidans infections

  • Shani Zilberman-Itskovich,
  • Edward Cohen,
  • Leonid-Arie Ploshansky,
  • Alexander Yusupov,
  • Ruth Bouganim,
  • Katie H. Jaffe,
  • Dror Marchaim

DOI
https://doi.org/10.1017/ash.2024.11
Journal volume & issue
Vol. 4

Abstract

Read online

Stenotrophomonas maltophilia and Achromobacter xylosoxidans are emerging nosocomial, non-glucose fermenting, Gram-negative pathogens. In this nested case-control trial, independent predictors for S. maltophilia infections were hemodialysis and recent antibiotic usage (overall), while recent usage of fluoroquinolones, was independently associated with A. xylosoxidans infections. Infections were independently associated with multiple worse outcomes.